Breast Cancer Patients at Intermediate to High Risk
1 clinical trials · Condition
◉ Watch Breast Cancer Patients at Intermediate to High Risk
| Record | Firm | Date |
|---|---|---|
| Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian Function Suppression in Hormone Receptor-Positive Early Breast Cancer Among Non-Low-Risk Premenopausal Women: A Real-World Study (NCT05801705) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2023-06-01 |
Track Breast Cancer Patients at Intermediate to High Risk automatically
Every clearance here is in the API, with alerts when new ones post.